Literature DB >> 3549281

C-myc expression is dissociated from DNA synthesis and cell division in Xenopus oocyte and early embryonic development.

F Godeau, H Persson, H E Gray, A B Pardee.   

Abstract

The combined use of a human c-myc probe and of an antibody raised against the human c-myc gene product demonstrated that the Xenopus cells contained a 2.5-kb c-myc transcript and synthesized a c-myc immunoreactive 65-kd polypeptide. In full-grown oocytes, p65c-myc was predominantly located in the nucleus. In non-dividing Xenopus oocytes c-myc mRNA was present at a steady-state level 10(4) times higher than that of growing somatic A6 cells. This very high level of c-myc transcript was reached early in oogenesis and remained constant thereafter. The rate of p65c-myc synthesis also reached high levels, but only in vitellogenic oocytes, suggesting a post-transcriptional control. Although the cell cycle is resumed at a very fast pace in developing embryos, no further increase in total embryonic content of c-myc RNA could be demonstrated up to the swimming tadpole stage. Furthermore, in embryos the rate of synthesis of p65c-myc decreased to a level markedly lower than that of cell cycle-arrested vitellogenic oocytes. This observation suggests that the function of the c-myc gene in the cell cycle may not be implicated directly in sustaining DNA synthesis or mitosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3549281      PMCID: PMC1167395          DOI: 10.1002/j.1460-2075.1986.tb04684.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  47 in total

1.  VARIATIONS IN THE SYNTHESIS OF STABLE RNA'S DURING OOGENESIS AND DEVELOPMENT OF XENOPUS LAEVIS.

Authors:  D D BROWN; E LITTNA
Journal:  J Mol Biol       Date:  1964-05       Impact factor: 5.469

2.  A general method for isolation of high molecular weight DNA from eukaryotes.

Authors:  N Blin; D W Stafford
Journal:  Nucleic Acids Res       Date:  1976-09       Impact factor: 16.971

3.  Oogenesis in Xenopus laevis (Daudin). I. Stages of oocyte development in laboratory maintained animals.

Authors:  J N Dumont
Journal:  J Morphol       Date:  1972-02       Impact factor: 1.804

4.  Regulation of RNA synthesis in fibroblasts during transition from resting to growing state.

Authors:  J C Mauck; H Green
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

5.  Polyadenylic acid-containing RNA in Xenopus laevis oocytes.

Authors:  M Rosbash
Journal:  J Mol Biol       Date:  1974-05-05       Impact factor: 5.469

6.  Nuclear pore flow rate of ribosomal RNA and chain growth rate of its precursor during oogenesis of Xenopus laevis.

Authors:  U Scheer
Journal:  Dev Biol       Date:  1973-01       Impact factor: 3.582

7.  Multiple forms of deoxyribonucleic acid-dependent ribonucleic acid polymerase in Xenopus laevis. Levels of activity during oocyte and embryonic development.

Authors:  R G Roeder
Journal:  J Biol Chem       Date:  1974-01-10       Impact factor: 5.157

8.  Non-coordinated accumulation and synthesis of 5S ribonucleic acid by ovaries of Xenopus laevis.

Authors:  P J Ford
Journal:  Nature       Date:  1971-10-22       Impact factor: 49.962

9.  Synthesis of ribosomal RNA in synchronized HeLa cells.

Authors:  M D Scharff; E Robbins
Journal:  Nature       Date:  1965-10-30       Impact factor: 49.962

10.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

View more
  16 in total

1.  Xp54, the Xenopus homologue of human RNA helicase p54, is an integral component of stored mRNP particles in oocytes.

Authors:  M Ladomery; E Wade; J Sommerville
Journal:  Nucleic Acids Res       Date:  1997-03-01       Impact factor: 16.971

2.  The 5' noncoding region of the human leukemia-associated oncogene BCR/ABL is a potent inhibitor of in vitro translation.

Authors:  A J Muller; O N Witte
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

3.  cis-acting translational effects of the 5' noncoding region of c-myc mRNA.

Authors:  N Parkin; A Darveau; R Nicholson; N Sonenberg
Journal:  Mol Cell Biol       Date:  1988-07       Impact factor: 4.272

Review 4.  Control of myogenic differentiation by cellular oncogenes.

Authors:  M D Schneider; E N Olson
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

5.  Localization in situ of c-myc mRNA and c-myc protein in adult mouse testis.

Authors:  T Koji; S Izumi; M Tanno; T Moriuchi; P K Nakane
Journal:  Histochem J       Date:  1988-10

6.  Injection of an antibody against a p21 c-Ha-ras protein inhibits cleavage in axolotl eggs.

Authors:  E Baltus; J Hanocq-Quertier; F Hanocq; J Brachet
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

7.  Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology.

Authors:  A De Benedetti; R E Rhoads
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

8.  Comparative analysis of the expression and oncogenic activities of Xenopus c-, N-, and L-myc homologs.

Authors:  N Schreiber-Agus; R Torres; J Horner; A Lau; M Jamrich; R A DePinho
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

9.  Developmentally regulated alternative splicing in the Xenopus laevis c-Myc gene creates an intron-1 containing c-Myc RNA present only in post-midblastula embryos.

Authors:  M W King
Journal:  Nucleic Acids Res       Date:  1991-10-25       Impact factor: 16.971

10.  TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR.

Authors:  H Park; M V Davies; J O Langland; H W Chang; Y S Nam; J Tartaglia; E Paoletti; B L Jacobs; R J Kaufman; S Venkatesan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.